Syphilis
Canadian Guidelines on Sexually Transmitted Infections - Syphilis
Diagnosis
- Syphilis serology – mainstay of syphilis diagnosis
- Syphilis enzyme immunoassay (EIA)
- Screening test in Alberta
- Measures IgM and IgG antibodies to Treponema pallidum (treponemal test)
- Usually remains positive lifelong even after successful therapy
- Rapid plasma reagin (RPR)
- In Alberta, RPR performed on all EIA positive specimens
- Measures cardiolipin antibodies (nontreponemal test)
- Reflects disease activity, indicator for treatment response and re-infection
- Treponema pallidum particle agglutination test (TPPA)
- Confirmatory test in Alberta
- Performed on all EIA positive specimens when clients test positive for the first time
NB: If high clinical suspicion for infectious syphilis but negative test result, repeat serology in 2-4 weeks. Syphilis serology may be false negative in early stages of disease.
2. Syphilis PCR of syphilitic lesions, chancres, skin and mucosal surfaces.
- Ulcers should also be tested for herpes simplex virus (HSV). Test for Chancroid +/- Lymphogranuloma venereum if syphilis and HSV negative and epidemiologic exposure (i.e. appropriate travel history or contact with a traveler).
- All patients with a diagnosis of syphilis should be tested for HIV.
Primary Syphilis
- Chancre – single painless genital ulcer (occasionally extragenital indurated ulcer) within 3 weeks of infection; may be multiple/painful (up to 30% co-infected with HSV)
- Regional lymphadenopathy 70-80%
- May resolve without treatment.
Secondary syphilis
- Highly infectious stage
- Multiple organ systems can be involved including generalized lymphadenopathy, hepatosplenomegaly, hepatitis, alopecia, oral lesions, pharyngitis, anterior uveitis, optic neuritis, meningitis, glomerulonephritis, periosteitis
- Cutaneous manifestations include macular/maculopapular/scaly lesions of face, torso and flexor aspects of extremities.
- Symptoms resolve without treatment within 6 months after primary infection.
Latent syphilis
- Seroreactivity without clinical evidence of disease:
Early < 1 year
Late > 1 year
Tertiary syphilis
- Cardiovascular disease, neurosyphilis, gumma
- Occurs years to decades after primary infection
Treatment failure
- Clinical progression or relapse of clinical symptoms or inadequate decline in RPR/VDRL titres.
- NB: Treponemal test usually remains positive lifelong even after successful therapy.
Primary, Secondary, Latent < 1 year duration (early)
- All sexual contacts of early syphilis should be tested and treated.
Treponema pallidum
Therapy | Dose | Duration |
---|---|---|
Benzathine Penicillin G | 2.4MU intragluteal | 1 dose, or weekly x 2 doses if pregnant |
ß-lactam allergy
Therapy | Dose | Duration |
---|---|---|
Doxycycline | 100mg PO bid | 14 days |
Alternative in ß-lactam allergic pregnant patients
Therapy | Dose | Duration |
---|---|---|
then | ||
Benzathine Penicillin G | 2.4MU intragluteal weekly | 2 doses |
Latent > 1 year duration (late) or unknown duration
- Evaluation (including lumbar puncture) to rule out tertiary syphilis should be done in consultation with an Infectious Diseases/STI specialist prior to treatment.
Treponema pallidum
Therapy | Dose | Duration |
---|---|---|
Benzathine Penicillin G | 2.4MU intragluteal weekly | 3 doses |
ß-lactam allergy
Therapy | Dose | Duration |
---|---|---|
Doxycycline | 100mg PO bid | 28 days |
Alternative in ß-lactam allergic pregnant patients
Therapy | Dose | Duration |
---|---|---|
Desensitization | ||
then | ||
Benzathine Penicillin G | 2.4MU intragluteal weekly | 3 doses |
Neurosyphilis, including ocular syphilis
- Recommend LP if:
- presence of neurologic or ophthalmic symptoms or signs
- previously treated patients without adequate serological treatment response
- tertiary syphilis
- Test CSF for:
- cell count and differential, protein
- VDRL and FTA-ABS.
Treponema pallidum
Therapy | Dose | Duration |
---|---|---|
Penicillin G | 3-4MU IV q4h | 10-14 days |
ß-lactam allergy
Therapy | Dose | Duration |
---|---|---|
Ceftriaxone | 2g IV daily | 10-14 days |